Business Context and Reporting Period
Company: The Campbell's Company (CPB)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended April 27, 2025 (Fiscal 2025 Q3)
Business Overview: A manufacturer and marketer of branded food and beverage products operating in two segments: Meals & Beverages and Snacks. The period includes the integration of the Sovos Brands acquisition (closed March 2024) and the divestiture of the noosa yoghurt business (closed February 2025).
Key Financial Metrics
| Metric (in millions, except per share) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $2,475 | $2,369 | $7,932 | $7,343 |
| Gross Profit Margin | 29.4% | 30.9% | 30.4% | 31.3% |
| Net Earnings | $66 | $133 | $457 | $570 |
| Diluted EPS | $0.22 | $0.44 | $1.52 | $1.91 |
| Operating Cash Flow (9M) | $872 | $897 | $872 | $897 |
| Total Debt (Short + Long Term) | $6,896 | $7,184 | $6,896 | $7,184 |
| Cash and Equivalents | $143 | $108 | $143 | $108 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% in Q3 and 8% year-to-date (YTD), driven primarily by the Sovos Brands acquisition (+12% in Q3, +19% YTD) and favorable volume/mix in the Meals & Beverages segment. This was partially offset by divestitures (Pop Secret, noosa) and lower net price realization.
- Profitability Decline: Net earnings dropped 50% in Q3 and 20% YTD. The decline is largely attributable to significant non-recurring charges, including a $150 million impairment charge on the Snyder's of Hanover trademark in Q3 and $176 million in total impairment charges YTD.
- Margin Compression: Gross profit margin decreased 150 basis points in Q3 and 90 basis points YTD due to cost inflation, supply chain costs, and unfavorable commodity hedge mark-to-market adjustments, partially offset by productivity improvements.
- Interest Expense: Interest expense increased 21% in Q3 ($85M vs $70M) and 58% YTD ($260M vs $165M) due to higher debt levels and interest rates associated with the Sovos acquisition financing.
Guidance, Outlook, and Risks
- Cost Savings Initiatives: The company announced 2025 cost savings initiatives targeting approximately $250 million in annual ongoing savings by the end of 2028. Total estimated pre-tax costs for these actions are approximately $210 million, with $150 million expected to be cash expenditures.
- Capital Expenditures: Expected to total approximately $450 million in 2025, focusing on manufacturing optimization and IT infrastructure (including SAP implementation for Sovos).
- Dividends: The quarterly dividend was maintained at $0.39 per share.
- Key Risks:
- Intangible Asset Impairment: Significant impairment charges were recognized for Snyder's of Hanover, Late July, and Allied brands due to sales performance below expectations. Management notes that other trademarks (e.g., Rao's, Pace, Pacific Foods) have limited excess coverage of fair value over carrying value, creating sensitivity to changes in assumptions.
- Tariffs and Trade: Ongoing monitoring of tariffs on China, Canada, Mexico, and the EU, which may increase costs and impact volumes.
- Commodity Volatility: Exposure to input cost inflation and commodity price fluctuations, partially hedged but subject to mark-to-market volatility.
Investor Verification Checklist
- Impairment Sensitivity: Verify the assumptions used in the fair value assessment of the Snyder's of Hanover and Rao's trademarks, given the recent $150M charge and the limited "excess coverage" noted for other brands.
- Debt Servicing: Confirm the company's ability to meet the 3.25:1.00 interest coverage ratio covenant under its credit facilities given the elevated interest expense.
- Cost Savings Realization: Monitor the progress of the 2025 cost savings initiatives to ensure the projected $250M annual savings are achieved without further significant one-time charges.
- Divestiture Adjustments: Review final purchase price adjustments for the noosa yoghurt sale to confirm the final loss impact.
- Working Capital: Assess the sustainability of the negative working capital position ($623M) driven by extended supplier payment terms and supplier finance programs.